About

A research-driven biopharmaceutical company focused on anti-infectives

EluciTx was founded in Beijing. We believe that, against constantly evolving pathogens, sustained scientific innovation and pragmatic clinical collaboration matter equally.

Company profile

Beijing EluciTx Biopharmaceutical Technology Co., Ltd. (合澄生物) is a biopharmaceutical company whose core activity is anti-infective drug research and development. We focus on drug-resistant, difficult-to-treat and recurrent bacterial and fungal infections. We are building an AI-enabled anti-infective discovery platform to identify and optimise new candidate molecules, and we study combination regimens and dosing strategies built on approved drugs, in search of safer, more effective and more accessible treatment options.

We operate a focused, asset-light research model and collaborate openly with clinical institutions, research organisations and contract research partners. Every programme starts from a clearly defined clinical problem and advances on rigorous evidence.

Our Chinese name, 合澄 (Hé Chéng), joins “合”, to bring together, with “澄”, to make clear: we gather strengths through collaboration and face complex infections with clear scientific understanding. The name EluciTx combines “elucidate” and “therapeutics”, expressing our aim of turning understanding of disease into real treatments.

Our purpose

Mission and vision

Mission

To provide safer, more effective and more accessible treatment options for patients with drug-resistant and difficult-to-treat infections.

Vision

To become a trusted partner in anti-infective drug discovery and development, so that every infection can be met with a clear and effective response.

How we work

Clarity

We let data and evidence speak, face uncertainty honestly, and are explicit about what we know and what we do not.

Collaboration

We work openly with front-line clinicians, research institutions and industry partners, and define our goals from real clinical problems.

Prudence

We respect the long timelines and high risk of drug development: staged validation, strict compliance, and patient safety first.

Company information

At a glance

Legal name
Beijing EluciTx Biopharmaceutical Technology Co., Ltd.
Chinese name
北京合澄生物医药科技有限公司
Address
14/F, Building 2, Shuangqing Building, Haidian District, Beijing, China

Contact us